Using two different pairs of TILs and autologous melanoma cells (see Materials and Methods), we found that supernatants from seven different M2-BCG donors enhanced GrB release from TILs by ~25% in response to their autologous tumor cells (Figure 4G). The gene discussed is GZMB; the disease is melanoma.